Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Daniela Mikhaylov, Ester Del Duca & Emma Guttman-Yassky. (2021) Proteomic signatures of inflammatory skin diseases: a focus on atopic dermatitis. Expert Review of Proteomics 18:5, pages 345-361.
Read now
Read now
Tiffany Y Loh, Jennifer L Hsiao & Vivian Y Shi. (2020) Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis. Journal of Asthma and Allergy 13, pages 109-114.
Read now
Read now
Kam Lun Hon, Steven Loo, Alexander K. C. Leung, Joyce T. S. Li & Vivian W. Y. Lee. (2020) An overview of drug discovery efforts for eczema: why is this itch so difficult to scratch?. Expert Opinion on Drug Discovery 15:4, pages 487-498.
Read now
Read now
Noha S. El-Salamouni, Mai M. Ali, Sherien A. Abdelhady, Lamia S. Kandil, Gihan A. Elbatouti & Ragwa M. Farid. (2020) Evaluation of chamomile oil and nanoemulgels as a promising treatment option for atopic dermatitis induced in rats. Expert Opinion on Drug Delivery 17:1, pages 111-122.
Read now
Read now
Nilika Bhattacharya, Gitali Ganguli-Indra & Arup K. Indra. (2019) Transcriptional control and transcriptomic analysis of lipid metabolism in skin barrier formation and atopic dermatitis (AD). Expert Review of Proteomics 16:8, pages 627-645.
Read now
Read now
Randall Li, Suhail Hadi & Emma Guttman-Yassky. (2019) Current and emerging biologic and small molecule therapies for atopic dermatitis. Expert Opinion on Biological Therapy 19:4, pages 367-380.
Read now
Read now
Sarfaraz Ahmad & Carlos M. Ferrario. (2018) Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010–2018). Expert Opinion on Therapeutic Patents 28:11, pages 755-764.
Read now
Read now
Yunlei Pan, Lina Xu, Jianjun Qiao & Hong Fang. (2018) A systematic review of ustekinumab in the treatment of atopic dermatitis. Journal of Dermatological Treatment 29:6, pages 539-541.
Read now
Read now
Kam Lun Hon, Alexander K.C. Leung, Theresa N. H. Leung & Vivian W. Y. Lee. (2018) Investigational drugs for atopic dermatitis. Expert Opinion on Investigational Drugs 27:8, pages 637-647.
Read now
Read now
Dylan E. Lee, Ashley K. Clark, Khiem A. Tran & Vivian Y. Shi. (2018) New and emerging targeted systemic therapies: a new era for atopic dermatitis. Journal of Dermatological Treatment 29:4, pages 364-374.
Read now
Read now
Laurie A. Manka & Michael E. Wechsler. (2018) New biologics for allergic diseases. Expert Review of Clinical Immunology 14:4, pages 285-296.
Read now
Read now
Marianne B Løvendorf & Lone Skov. (2015) miRNAs in inflammatory skin diseases and their clinical implications. Expert Review of Clinical Immunology 11:4, pages 467-477.
Read now
Read now
Articles from other publishers (72)
Jefferson Russo Victor & Dong-Ho Nahm. (2023) Mechanism underlying polyvalent IgG-induced regulatory T cell activation and its clinical application: Anti-idiotypic regulatory T cell theory for immune tolerance. Frontiers in Immunology 14.
Crossref
Crossref
Krzysztof Sitko, Michał Starke & Stefan Tukaj. (2023) Heat shock protein 90 (Hsp90) inhibitor STA-9090 (Ganetespib) ameliorates inflammation in a mouse model of atopic dermatitis. Cell Stress and Chaperones.
Crossref
Crossref
Jessica S. S. Ho & Sonja Molin. (2023) A Review of Existing and New Treatments for the Management of Hand Eczema. Journal of Cutaneous Medicine and Surgery 27:5, pages 493-503.
Crossref
Crossref
Hyocheong Chae. (2023) 1 Case of a Chronic Atopic Dermatitis Patient Who Improved with a Combined Korean Medicine: Focusing on Yang-geum-hwa Pharmacopuncture. Journal of Korean Medical Society of Acupotomology 7:1, pages 40-43.
Crossref
Crossref
Arezoo Moini Jazani, Mohammad Hossein Ayati, Ata Allah Nadiri & Ramin Nasimi Doost Azgomi. (2022) Efficacy of hydrotherapy, spa therapy, and balneotherapy for psoriasis and atopic dermatitis: a systematic review. International Journal of Dermatology 62:2, pages 177-189.
Crossref
Crossref
Dong-Ho Nahm, Myoung-Eun Kim, Byul Kwon, Ji Su Kim & Bumhee Park. (2023) Intramuscular Injection of Autologous Serum in Adolescent and Adult Patients with Atopic Dermatitis: A Preliminary Randomized Clinical Trial. Yonsei Medical Journal 64:7, pages 423.
Crossref
Crossref
Fotios Koskeridis, Evangelos Evangelou, Evangelia E. Ntzani, Konstantinos Kostikas & Sophia Tsabouri. (2022) Treatment With Dupilumab in Patients With Atopic Dermatitis: Systematic Review and Meta-Analysis. Journal of Cutaneous Medicine and Surgery 26:6, pages 613-621.
Crossref
Crossref
Ga-Yul Min, Tae In Kim, Ji-Hye Kim, Won-Kyung Cho, Ju-Hye Yang & Jin-Yeul Ma. (2022) Inhibitory effect of Isatis tinctoria L. water extract on DNCB-induced atopic dermatitis in BALB/c mice and HaCaT cells. Chinese Medicine 17:1.
Crossref
Crossref
Velpula Prasannanjaneyulu, Shweta Nene, Harsha Jain, Rimsha Nooreen, Shivam Otavi, Palak Chitlangya & Saurabh Srivastava. (2022) Old drugs, new tricks: Emerging role of drug repurposing in the management of atopic dermatitis. Cytokine & Growth Factor Reviews 65, pages 12-26.
Crossref
Crossref
Sukhbir Singh, Tapan Behl, Neelam Sharma, Ishrat Zahoor, Sridevi Chigurupati, Shivam Yadav, Mahesh Rachamalla, Aayush Sehgal, Tanveer Naved, Pritima, Sandeep Arora, Saurabh Bhatia, Ahmed Al-Harrasi, Syam Mohan, Lotfi Aleya & Simona Bungau. (2022) Targeting therapeutic approaches and highlighting the potential role of nanotechnology in atopic dermatitis. Environmental Science and Pollution Research 29:22, pages 32605-32630.
Crossref
Crossref
Ga-Yul Min, Ji-Hye Kim, Tae-In Kim, Won-Kyung Cho, Ju-Hye Yang & Jin-Yeul Ma. (2022) Indigo Pulverata Levis (Chung-Dae, Persicaria tinctoria) Alleviates Atopic Dermatitis-like Inflammatory Responses In Vivo and In Vitro. International Journal of Molecular Sciences 23:1, pages 553.
Crossref
Crossref
Krzysztof Sitko, Marta Bednarek, Jagoda Mantej, Magdalena Trzeciak & Stefan Tukaj. (2021) Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis. Cell Stress and Chaperones 26:6, pages 1001-1007.
Crossref
Crossref
Daniela Mikhaylov, Ester Del Duca, Caroline Meyer Olesen, Helen He, Jianni Wu, Benjamin Ungar, Yeriel Estrada, Ning Zhang, Mashkura Chowdhury, Maja-Lisa Clausen, James G. Krueger, Ana B. Pavel, Tove Agner & Emma Guttman-Yassky. (2021) Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With Dupilumab. Dermatitis 32:1S, pages S71-S80.
Crossref
Crossref
Ravi Raj Pal, Anish Kumar Maurya, Poonam Parashar & Shubhini A. Saraf. (2020) A Comparative Study of Levocetirizine Loaded Vesicular and Matrix Type System for Topical Application: Appraisal of Therapeutic Potential against Atopic Dermatitis. Journal of Pharmaceutical Innovation 16:3, pages 469-480.
Crossref
Crossref
Xueli Cheng, Jiawen Lai, Yuelin Zhang, Liyun Lin, Donghan Xu, Zhenghong Zhong, Qibiao Wu & Jing Liu. (2021) Efficacy and safety of fire acupuncture for psoriasis vulgaris. Medicine 100:12, pages e25038.
Crossref
Crossref
Kwang Hoon Lee & Chang Ook Park. 2021. Practical Insights into Atopic Dermatitis. Practical Insights into Atopic Dermatitis
133
153
.
Agatha Stegemann & Markus Böhm. (2020) Targeting the α7 nicotinic acetylcholine receptor–A novel road towards the future treatment of skin diseases. Experimental Dermatology 29:9, pages 924-931.
Crossref
Crossref
Sara N. Bilimoria & Peter A. Lio. (2020) Biologics for Allergic Dermatologic Diseases. Current Allergy and Asthma Reports 20:8.
Crossref
Crossref
T.H. Andreasen, M.O. Christensen, A.‐S. Halling, A. Egeberg & J.P. Thyssen. (2020) Placebo response in phase 2 and 3 trials of systemic and biological therapies for atopic dermatitis—a systematic review and meta‐analysis. Journal of the European Academy of Dermatology and Venereology 34:6, pages 1143-1150.
Crossref
Crossref
Na-Hee Jeong, Soyoung Lee, Jin Kyeong Choi, Young-Ae Choi, Min-Jong Kim, Hyun-Shik Lee, Tae-Yong Shin, Yong Hyun Jang, Kyung-Sik Song & Sang-Hyun Kim. (2020) Polyozellin alleviates atopic dermatitis-like inflammatory and pruritic responses in activated keratinocytes and mast cells. Biomedicine & Pharmacotherapy 122, pages 109743.
Crossref
Crossref
Koichi Ando, Akihiko Tanaka & Hironori Sagara. (2020) Comparative Efficacy and Safety of Dupilumab and Benralizumab in Patients with Inadequately Controlled Asthma: A Systematic Review. International Journal of Molecular Sciences 21:3, pages 889.
Crossref
Crossref
Dong-Ho Nahm, Young-Min Ye, Yoo Seob Shin, Hae-Sim Park, Myoung-Eun Kim, Byul Kwon, Su-Mi Cho & Jinjoo Han. (2020) Efficacy, Safety, and Immunomodulatory Effect of the Intramuscular Administration of Autologous Total Immunoglobulin G for Atopic Dermatitis: A Randomized Clinical Trial. Allergy, Asthma & Immunology Research 12:6, pages 949.
Crossref
Crossref
Peter H. Schafer, Mary Adams, Gerald Horan, Francesca Truzzi, Alessandra Marconi & Carlo Pincelli. (2019) Apremilast Normalizes Gene Expression of Inflammatory Mediators in Human Keratinocytes and Reduces Antigen-Induced Atopic Dermatitis in Mice. Drugs in R&D 19:4, pages 329-338.
Crossref
Crossref
B. Akinlade, E. Guttman‐Yassky, M. Bruin‐Weller, E.L. SimpsonA. Blauvelt, M.J. CorkE. Prens, P. AsbellE. AkpekJ. CorrenC. Bachert, I. HiranoJ. WeyneA. KorotzerZ. ChenT. HultschX. ZhuJ.D. DavisL. Mannent, J.D. HamiltonA. TeperH. StaudingerE. RizovaG. PirozziN.M.H. GrahamB. ShumelM. ArdeleanuA. Wollenberg. (2019) Conjunctivitis in dupilumab clinical trials. British Journal of Dermatology 181:3, pages 459-473.
Crossref
Crossref
Emma Guttman-Yassky, Ana B. Pavel, Lisa Zhou, Yeriel D. Estrada, Ning Zhang, Hui Xu, Xiangyu Peng, Huei-Chi Wen, Panayiota Govas, Girish Gudi, Vinu CA, Hui Fang, Yacine Salhi, Jonathan Back, Venkateshwar Reddy, Robert Bissonnette, Catherine Maari, Fred Grossman & Gerhard Wolff. (2019) GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology 144:2, pages 482-493.e7.
Crossref
Crossref
S. Williamson, J. MerrittA. De Benedetto. (2019) Atopic dermatitis in the elderly: a review of clinical and pathophysiological hallmarks. British Journal of Dermatology.
Crossref
Crossref
Nilika Bhattacharya, William J. Sato, Avalon Kelly, Gitali Ganguli-Indra & Arup K. Indra. (2019) Epidermal Lipids: Key Mediators of Atopic Dermatitis Pathogenesis. Trends in Molecular Medicine 25:6, pages 551-562.
Crossref
Crossref
Charles W. Lynde, James Bergman, Loretta Fiorillo, Lyn Guenther, Jill Keddy-Grant, Ian Landells, Danielle Marcoux, Michele Ramien & Wingfield Rehmus. (2019) Clinical Insights About Topical Treatment of Mild-to-Moderate Pediatric and Adult Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery 23:3_suppl, pages 3S-13S.
Crossref
Crossref
Griffin R. Lee, Melody Maarouf, Aleksi K. Hendricks, Dylan E. Lee & Vivian Y. Shi. (2019) Current and emerging therapies for hand eczema. Dermatologic Therapy 32:3.
Crossref
Crossref
Yael Renert-Yuval & Emma Guttman-Yassky. (2019) What’s New in Atopic Dermatitis. Dermatologic Clinics 37:2, pages 205-213.
Crossref
Crossref
Susan Mayor. (2019) Translating Evidence to Practice: From Clinical Research to Real-World Experience. EMJ Dermatology, pages 2-12.
Crossref
Crossref
Emma Guttman-Yassky, Robert Bissonnette, Benjamin Ungar, Mayte Suárez-Fariñas, Marius Ardeleanu, Hitokazu Esaki, Maria Suprun, Yeriel Estrada, Hui Xu, Xiangyu Peng, Jonathan I. Silverberg, Alan Menter, James G. Krueger, Rick Zhang, Usman Chaudhry, Brian Swanson, Neil M.H. Graham, Gianluca Pirozzi, George D. Yancopoulos & Jennifer D. D. Hamilton. (2019) Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology 143:1, pages 155-172.
Crossref
Crossref
Leila Ferguson, Masaki Futamura, Efstratios Vakirlis, Reiji Kojima, Hatoko Sasaki, Amanda Roberts & Rintaro Mori. (2018) Leukotriene receptor antagonists for eczema. Cochrane Database of Systematic Reviews 2018:10.
Crossref
Crossref
Na-Ra Han, Phil-Dong Moon, Min-Sun Yoo, Ka-Jung Ryu, Hyung-Min Kim & Hyun-Ja Jeong. (2018) Regulatory effects of chrysophanol, a bioactive compound of AST2017-01 in a mouse model of 2,4-dinitrofluorobenzene-induced atopic dermatitis. International Immunopharmacology 62, pages 220-226.
Crossref
Crossref
Yael Renert-Yuval & Emma Guttman-Yassky. (2018) Monoclonal antibodies for the treatment of atopic dermatitis. Current Opinion in Allergy & Clinical Immunology 18:4, pages 356-364.
Crossref
Crossref
George Man, Li-zhi Hu, Peter M Elias & Mao-qiang Man. (2017) Therapeutic Benefits of Natural Ingredients for Atopic Dermatitis. Chinese Journal of Integrative Medicine 24:4, pages 308-314.
Crossref
Crossref
Won-Ju Kim, Ja-Hyun Koo, Hyun-Jung Cho, Jae-Ung Lee, Ji Yun Kim, Hong-Gyun Lee, Sohee Lee, Jong Hoon Kim, Mi Seon Oh, Minah Suh, Eui-Cheol Shin, Joo Yeon Ko, Myung Hyun Sohn & Je-Min Choi. (2018) Protein tyrosine phosphatase conjugated with a novel transdermal delivery peptide, astrotactin 1–derived peptide recombinant protein tyrosine phosphatase (AP-rPTP), alleviates both atopic dermatitis–like and psoriasis-like dermatitis. Journal of Allergy and Clinical Immunology 141:1, pages 137-151.
Crossref
Crossref
Mark Boguniewicz, Luz Fonacier, Emma Guttman-Yassky, Peck Y. Ong, Jonathan Silverberg & Judith Rosen Farrar. (2018) Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape. Annals of Allergy, Asthma & Immunology 120:1, pages 10-22.e2.
Crossref
Crossref
A. Sicras-Mainar, R. Navarro-Artieda & J.M. Carrascosa Carrillo. (2018) Economic Impact of Atopic Dermatitis in Adults: A Population-Based Study (IDEA Study). Actas Dermo-Sifiliográficas (English Edition) 109:1, pages 35-46.
Crossref
Crossref
A. Sicras-Mainar, R. Navarro-Artieda & J.M. Carrascosa Carrillo. (2018) Impacto económico de la dermatitis atópica en adultos: estudio de base poblacional (estudio IDEA). Actas Dermo-Sifiliográficas 109:1, pages 35-46.
Crossref
Crossref
Katrina Harper-Kirksey. 2018. Life-Threatening Rashes. Life-Threatening Rashes
265
277
.
Ilja Ovsiy, Vladimir Riabov, Ioannis Manousaridis, Julia Michel, Kondaiah Moganti, Shuiping Yin, Tengfei Liu, Carsten Sticht, Elisabeth Kremmer, Martin C. Harmsen, Sergij Goerdt, Alexei Gratchev & Julia Kzhyshkowska. (2017) IL-4 driven transcription factor FoxQ1 is expressed by monocytes in atopic dermatitis and stimulates monocyte migration. Scientific Reports 7:1.
Crossref
Crossref
R.J. SamuelN.J. Reynolds. (2017) Ustekinumab for severe atopic dermatitis: an important negative study. British Journal of Dermatology 177:2, pages 339-341.
Crossref
Crossref
Yael Renert-Yuval & Emma Guttman-Yassky. (2017) Systemic therapies in atopic dermatitis: The pipeline. Clinics in Dermatology 35:4, pages 387-397.
Crossref
Crossref
Hongfei Lou, Jingning Lu, Eun Byul Choi, Min Hee Oh, Mingeum Jeong, Sara Barmettler, Zhou Zhu & Tao Zheng. (2017) Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway. The Journal of Immunology 198:7, pages 2543-2555.
Crossref
Crossref
Patrick M. Brunner, Emma Guttman-Yassky & Donald Y.M. Leung. (2017) The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. Journal of Allergy and Clinical Immunology 139:4, pages S65-S76.
Crossref
Crossref
Dayana Abboud & Julien Hanson. (2017) Chemokine neutralization as an innovative therapeutic strategy for atopic dermatitis. Drug Discovery Today 22:4, pages 702-711.
Crossref
Crossref
Ching-Ying Wu, Ying-Yi Lu, Chun-Ching Lu, Yu-Feng Su, Tai-Hsin Tsai & Chieh-Hsin Wu. (2017) Osteoporosis in adult patients with atopic dermatitis: A nationwide population-based study. PLOS ONE 12:2, pages e0171667.
Crossref
Crossref
Özge Uluçkan & Erwin F. Wagner. (2017) Chronic systemic inflammation originating from epithelial tissues. The FEBS Journal 284:4, pages 505-516.
Crossref
Crossref
Judith L. Thijs, Marjolein S. de Bruin-Weller & DirkJan Hijnen. (2017) Current and Future Biomarkers in Atopic Dermatitis. Immunology and Allergy Clinics of North America 37:1, pages 51-61.
Crossref
Crossref
Doris Weiss, Michaela Schaschinger, Robin Ristl, Robert Gruber, Tamara Kopp, Georg Stingl & Christine Bangert. (2017) Ustekinumab treatment in severe atopic dermatitis: Down-regulation of T-helper 2/22 expression. Journal of the American Academy of Dermatology 76:1, pages 91-97.e3.
Crossref
Crossref
Nupur Patel & Lindsay C. Strowd. 2017. Management of Atopic Dermatitis. Management of Atopic Dermatitis
185
210
.
Thuy L. Phung, Teresa S. Wright, Crystal Y. Pourciau & Bruce R. SmollerThuy L. Phung, Teresa S. Wright, Crystal Y. Pourciau & Bruce R. Smoller. 2017. Pediatric Dermatopathology. Pediatric Dermatopathology
1
22
.
Lloyd S. Miller. 2017. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology
265
288
.
Niklas Palmqvist, Max Siller, Cecilia Klint & Anders Sjödin. (2016) A human and animal model-based approach to investigating the anti-inflammatory profile and potential of the 5-HT2B receptor antagonist AM1030. Journal of Inflammation 13:1.
Crossref
Crossref
Margeaux Oliva, Yael Renert-Yuval & Emma Guttman-Yassky. (2016) The ‘omics’ revolution: redefining the understanding and treatment of allergic skin diseases. Current Opinion in Allergy & Clinical Immunology 16:5, pages 469-476.
Crossref
Crossref
Hern-Tze Tina Tan, Kazunari Sugita & Cezmi A. Akdis. (2016) Novel Biologicals for the Treatment of Allergic Diseases and Asthma. Current Allergy and Asthma Reports 16:10.
Crossref
Crossref
Ehrin J. Armstrong & James G. Krueger. (2016) Lipoprotein Metabolism and Inflammation in Patients With Psoriasis. The American Journal of Cardiology 118:4, pages 603-609.
Crossref
Crossref
Christine Bangert. (2016) Neue Wirkstoffe in der Pipeline zur Behandlung der atopischen Dermatitis. ?sthetische dermatologie & kosmetologie 8:2, pages 17-22.
Crossref
Crossref
Debajyoti Ghosh, Lili Ding, Umasundari Sivaprasad, Esmond Geh, Jocelyn Biagini Myers, Jonathan A. Bernstein, Gurjit K Khurana Hershey & Tesfaye B. Mersha. (2015) Multiple Transcriptome Data Analysis Reveals Biologically Relevant Atopic Dermatitis Signature Genes and Pathways. PLOS ONE 10:12, pages e0144316.
Crossref
Crossref
David A. Ewald, Dana Malajian, James G. Krueger, Christopher T. Workman, Tianjiao Wang, Suyan Tian, Thomas Litman, Emma Guttman-Yassky & Mayte Suárez-Fariñas. (2015) Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways. BMC Medical Genomics 8:1.
Crossref
Crossref
Christine Bangert. (2015) Ein Silberstreif am Horizont ? was ist in der Pipeline an neuen Wirkstoffen bei atopischer Dermatitis?Silver lining on the horizon ? what is in the pipeline regarding new drugs for atopic dermatitis?. hautnah 14:4, pages 82-89.
Crossref
Crossref
Laetitia Furio, Georgios Pampalakis, Iacovos P. Michael, Andras Nagy, Georgia Sotiropoulou & Alain Hovnanian. (2015) KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome. PLOS Genetics 11:9, pages e1005389.
Crossref
Crossref
O. Boyman, C. Kaegi, M. Akdis, S. Bavbek, A. Bossios, A. Chatzipetrou, T. Eiwegger, D. Firinu, T. Harr, E. Knol, A. Matucci, O. Palomares, C. Schmidt-Weber, H.-U. Simon, U. C. Steiner, A. Vultaggio, C. A. Akdis & F. Spertini. (2015) EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy 70:7, pages 727-754.
Crossref
Crossref
Kyung Eun Jung, Ye Jin Lee, Yun Hee Ryu, Jung Eun Kim, Hei Sung Kim, Beom Joon Kim, Hoon Kang & Young Min Park. (2015) Effects of topically applied rapamycin and mycophenolic acid on TNCB-induced atopic dermatitis-like skin lesions in NC/Nga mice. International Immunopharmacology 26:2, pages 432-438.
Crossref
Crossref
Yasaman Mansouri & Emma Guttman-Yassky. (2015) Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics. Journal of Clinical Medicine 4:5, pages 858-873.
Crossref
Crossref
Hitokazu Esaki, David A. Ewald, Benjamin Ungar, Mariya Rozenblit, Xiuzhong Zheng, Hui Xu, Yeriel D. Estrada, Xiangyu Peng, Hiroshi Mitsui, Thomas Litman, Mayte Suárez-Fariñas, James G. Krueger & Emma Guttman-Yassky. (2015) Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection. Journal of Allergy and Clinical Immunology 135:1, pages 153-163.
Crossref
Crossref
Saakshi Khattri, Avner Shemer, Mariya Rozenblit, Nikhil Dhingra, Tali Czarnowicki, Robert Finney, Patricia Gilleaudeau, Mary Sullivan-Whalen, Xiuzhong Zheng, Hui Xu, Irma Cardinale, Cristina de Guzman Strong, Juana Gonzalez, Mayte Suárez-Fariñas, Jim G. Krueger & Emma Guttman-Yassky. (2014) Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology. Journal of Allergy and Clinical Immunology 133:6, pages 1626-1634.
Crossref
Crossref
D. Staumont-Sallé. (2014) Applications des biomédicaments dans la dermatite atopique et l’urticaire chronique. Revue Française d'Allergologie 54:3, pages 152-156.
Crossref
Crossref
Laetitia Furio, Simon de Veer, Madeleine Jaillet, Anais Briot, Aurelie Robin, Celine Deraison & Alain Hovnanian. (2014) Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome. Journal of Experimental Medicine 211:3, pages 499-513.
Crossref
Crossref
Prescilla V. Jeurink, Laura A. P. D. Meulenbroek, Johan Garssen & Léon M. J. Knippels. 2014. Pharma-Nutrition. Pharma-Nutrition
373
391
.
I. Koren Carmi, R. Haj, H. Yehuda, S. Tamir & A. Z. Reznick. 2015. Environmental Biomedicine. Environmental Biomedicine
1
10
.